Copyright
©2014 Baishideng Publishing Group Inc.
World J Nephrol. Nov 6, 2014; 3(4): 210-219
Published online Nov 6, 2014. doi: 10.5527/wjn.v3.i4.210
Published online Nov 6, 2014. doi: 10.5527/wjn.v3.i4.210
Clinical intervention | Ref. |
Lifestyle modification: weight reduction, dietary adjustment (calorie and phosphate reduction), increased physical activity, and/or smoking cessation | [91-94] |
Weight loss medication (orlistat) or surgery | [95,97] |
Lipid-lowering medication (statins, fibrates) | [96,104,105] |
Blood pressure-lowering medication (renin-angiotensin system antagonists) | [100] |
Blood glucose-lowering medication (metformin, thiazolidinediones) | [102,103] |
- Citation: Prasad GVR. Metabolic syndrome and chronic kidney disease: Current status and future directions. World J Nephrol 2014; 3(4): 210-219
- URL: https://www.wjgnet.com/2220-6124/full/v3/i4/210.htm
- DOI: https://dx.doi.org/10.5527/wjn.v3.i4.210